Angi Calkins Appointed as Chief Human Resources Officer
Calkins to lead global human resource team during time of considerable expansion
PCI is pleased to announce the appointment of Angi Calkins as Senior Vice President and Chief Human Resources Officer. Angi joins PCI as we experience considerable growth and global expansion, currently with more than 3,500 associates, spanning eight locations comprised of 20 facilities across three continents. PCI features a broad portfolio of outsourced development and commercialization services focused in drug development and manufacturing, clinical trial supply, as well as commercial contract packaging.
Angi brings significant experience to PCI gained during an impressive career in human resources leadership across multiple and diverse industries including pharmaceutical and life sciences, retail, consumer goods, global HR outsourcing and financial services. Angi joins us having served in senior leadership roles at Regeneron Pharmaceuticals, a leading biotechnology company that doubled in size, was recognized each year by Forbes as one of the 100 Greatest Places to Work, and was ranked the industry’s number one Biopharma Employer by Science Magazine during three of her four years in post
Commenting on Angi’s appointment, Chief Executive Officer Salim Haffar noted: “PCI is at a transformative time. We have a celebrated history of partnering with leading pharmaceutical and biotech companies to support bringing their life-saving medicines to patients around the world. Building on those trusted relationships, over the past 12 months we have changed the complexion of the company with acquisitions in key geographies including Dublin, Ireland; Melbourne, Australia; and San Diego, California, bringing new capabilities and greater access to global emerging markets.
“Our company is rich in cutting-edge science and technology, rooted in a dedication to outstanding service and quality. This is achieved through a talented and dedicated workforce. I am very pleased to have Angi join at such an exciting time and am eager to see her insights and leadership help shape the future of the company.”
“I am delighted for this opportunity,” stated Angi. “
In addition to key acquisitions in Melbourne, Australia and San Diego, California, we recently broke ground on site expansion at our Rockford, Illinois facility. This complements recently executed site expansions at our European clinical Center of Excellence in Bridgend and our manufacturing Center of Excellence in Tredegar, UK as well as investments at sites in Dublin, Ireland; Hay-on-Wye, UK; and Philadelphia, PA.
January 28, 2019